Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uremic toxin adsorption refers to the process of physically adsorbing and removing uremic toxins—substances that accumulate in patients with impaired renal function—from blood or the gastrointestinal tract by means of adsorbent materials. This approach targets toxins that conventional dialysis does not efficiently eliminate, especially those that are protein-bound, aiming to alleviate CKD-related complications and improve patient outcomes.
Adsorption/removal of toxins via physical binding to adsorbent materials in extracorporeal or gastrointestinal settings
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uremic toxin adsorption.